Epidural morphine in children: pharmacokinetics and CO2 sensitivity

Area of Science:

• Pediatric Anesthesiology
• Pain Management
• Pharmacology

Background:

• Postoperative pain management in children is crucial for recovery.
• Epidural analgesia offers an effective option for managing surgical pain.
• Limited data exists on epidural morphine's specific effects in pediatric surgical patients.

Purpose of the Study:

• To evaluate the efficacy and safety of epidural morphine for pain relief in children undergoing abdominal and urologic surgery.
• To assess the duration of analgesia and identify potential side effects.
• To investigate the impact of epidural morphine on respiratory control and pharmacokinetics in pediatric patients.

Main Methods:

• A study involving 20 children (ages 2-15 years) receiving epidural morphine (50 µg/kg) post-surgery.
• Assessment of pain onset and duration, side effects, and respiratory variables.
• Measurement of plasma morphine concentrations and pharmacokinetic analysis in a subset of patients.

Main Results:

• Effective analgesia with an onset of 30 minutes and duration of 19.5 hours.
• Common side effects included nausea, vomiting, and urinary retention; no apnea observed.
• A decrease in ventilatory response to CO2 was noted post-surgery and persisted after morphine administration.
• Pediatric pharmacokinetics showed a shorter half-life compared to adults, attributed to higher clearance.

Conclusions:

• Epidural morphine provides effective and prolonged pain relief in children following abdominal and urologic procedures.
• Prolonged respiratory depression is a potential risk, necessitating vigilant monitoring for at least 24 hours.
• The pharmacokinetic profile in children differs from adults, with higher morphine clearance.